Back to search

Italy· 025293034

TINSET*orale gocce 30 ml 2,5%

A oxatomide product containing oxatomide, registered in Italy by GRUNENTHAL ITALIA Srl, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC R06AE06

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedTINSET*orale gocce 30 ml 2,5%ATCR06AE06REGISTER NO.025293034PACKS LISTED1CHECKEDJune 4, 2026

Where it is registered

Oxatomide is registered in 2 of 19 countries.

Countries holding a registration under ATC R06AE06 (oxatomide), each read from that country’s own register.

  • This record: Italy
  • 1 of them publish a price we can compare per daily dose

Oxatomide · ATC R06AE06

2 / 19 countries

  • Italyprice
  • Japan
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxatomide costs, country by country.

Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.

  • Italy: $0.41 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Oxatomide · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.41
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Oxatomide
Manufacturer
GRUNENTHAL ITALIA Srl
Country
Italy (IT)
ATC code
R06AE06
ATC class
Oxatomide
Defined daily dose
60 mg, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    025293034
    TINSET*orale gocce 30 ml 2,5%
    EUR 4.98

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dbca4450-afc2-420d-82ee-e81eefd1ba88
GET /v1/drugs/dbca4450-afc2-420d-82ee-e81eefd1ba88?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 4.98,
  "source": "aifa",
  "currency": "EUR",
  "strength": "OXATOMIDE 2,5% 30ML USO ORALE",
  "substance": "Oxatomide",
  "equivalence_group": "PTA",
  "transparency_flag": null
}

See everything about oxatomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.